ALLIANCE A052101

Primary Category:

Treatment Protocols

Disease Category:

Lymphoma, Mantle Cell Lymphoma

Status:

New, Open

A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma

NCT#05976763